Gut bacteria and diet may hold new keys for triple-negative breast cancer care

Triple-negative breast cancer is a tough diagnosis. It lacks the usual targets doctors use to fight the disease. This narrative review looks at a different angle: the gut microbiome. It asks if the bacteria living in our intestines can help or hurt cancer growth. It also asks if taking antibiotics or gaining weight changes the picture. The authors suggest that diet and targeted interventions might offer new ways to manage this condition. They hope this knowledge will lead to better outcomes for patients facing this specific type of cancer. The review does not report specific numbers or trial results. Instead, it gathers existing information to show where science stands today. The goal is clear: to help doctors optimize care and improve lives. We must remember this is a review, not a clinical trial with hard data. The field is still learning how these factors connect to cancer. But the potential for change is real and worth watching closely.